Skip to content

Oral polymyxin for decolonization of Carbapenem-resistant gram-negative organism (CRO) in intestinal: A Prospective, Multicenter, Randomized Controlled Study

Oral polymyxin for decolonization of Carbapenem-resistant gram-negative organism (CRO) in intestinal: A Prospective, Multicenter, Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090612
Enrollment
Unknown
Registered
2024-10-10
Start date
2024-10-14
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intestinal colonization of carbapenem-resistant organism

Interventions

experimental group:oral polymyxin tablets
control group:None

Sponsors

Zhejiang Provincial People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) age = 18 years old 2) intestinal colonization of CRO is confirmed by rectal swab or fecal microbial culture 3) voluntarily participate in this study and sign the informed consent form; if the subject is unable to understand or sign the informed consent form, their legal representative will act on their behalf in the informed process and agree to their participation in this study

Exclusion criteria

Exclusion criteria: 1)The CRO strains colonized are resistant to polymyxins 2)Women who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
the clearance of CRO colonized in intestinal;

Secondary

MeasureTime frame
the MIC of CRO colonized in the instestine;

Countries

CHINA

Contacts

Public ContactYu Yunsong

Zhejiang Provincial People’s Hospital

yvys119@163.com+86 138 0579 0432

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026